These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 27082730)

  • 21. Tumor suppressive miR-196a is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma.
    Li Y; Jin L; Chen D; Liu J; Su Z; Yang S; Gui Y; Mao X; Nie G; Lai Y
    Mol Med Rep; 2016 Jul; 14(1):560-6. PubMed ID: 27175581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COP1 is downregulated in renal cell carcinoma (RCC) and inhibits the migration of RCC ACHN cells in vitro.
    Ta L; Xuan C; Xing N; Zhu X
    Mol Med Rep; 2016 Aug; 14(2):1371-8. PubMed ID: 27278120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA‑212 inhibits the proliferation and invasion of human renal cell carcinoma by targeting FOXA1.
    Tong Z; Meng X; Wang J; Wang L
    Mol Med Rep; 2018 Jan; 17(1):1361-1367. PubMed ID: 29115609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-134 functions as a tumor suppressor in cell proliferation and epithelial-to-mesenchymal Transition by targeting KRAS in renal cell carcinoma cells.
    Liu Y; Zhang M; Qian J; Bao M; Meng X; Zhang S; Zhang L; Zhao R; Li S; Cao Q; Li P; Ju X; Lu Q; Li J; Shao P; Qin C; Yin C
    DNA Cell Biol; 2015 Jun; 34(6):429-36. PubMed ID: 25811077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epithelial-mesenchymal transition-related microRNA-200s regulate molecular targets and pathways in renal cell carcinoma.
    Yoshino H; Enokida H; Itesako T; Tatarano S; Kinoshita T; Fuse M; Kojima S; Nakagawa M; Seki N
    J Hum Genet; 2013 Aug; 58(8):508-16. PubMed ID: 23635949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miRNA-205 is a candidate tumor suppressor that targets ZEB2 in renal cell carcinoma.
    Chen Z; Tang ZY; He Y; Liu LF; Li DJ; Chen X
    Oncol Res Treat; 2014; 37(11):658-64. PubMed ID: 25427583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor-suppressive microRNA-1291 directly regulates glucose transporter 1 in renal cell carcinoma.
    Yamasaki T; Seki N; Yoshino H; Itesako T; Yamada Y; Tatarano S; Hidaka H; Yonezawa T; Nakagawa M; Enokida H
    Cancer Sci; 2013 Nov; 104(11):1411-9. PubMed ID: 23889809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. microRNA-451 inhibited cell proliferation, migration and invasion through regulation of MIF in renal cell carcinoma.
    Tang Y; Wan W; Wang L; Ji S; Zhang J
    Int J Clin Exp Pathol; 2015; 8(12):15611-21. PubMed ID: 26884830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-28-5p acts as a tumor suppressor in renal cell carcinoma for multiple antitumor effects by targeting RAP1B.
    Wang C; Wu C; Yang Q; Ding M; Zhong J; Zhang CY; Ge J; Wang J; Zhang C
    Oncotarget; 2016 Nov; 7(45):73888-73902. PubMed ID: 27729617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-21 functions as an oncogene and promotes cell proliferation and invasion via TIMP3 in renal cancer.
    Chen J; Gu Y; Shen W
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4566-4576. PubMed ID: 29131259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-203 inhibition of renal cancer cell proliferation, migration and invasion by targeting of FGF2.
    Xu M; Gu M; Zhang K; Zhou J; Wang Z; Da J
    Diagn Pathol; 2015 Apr; 10():24. PubMed ID: 25890121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rab25 upregulation correlates with the proliferation, migration, and invasion of renal cell carcinoma.
    Li Y; Jia Q; Zhang Q; Wan Y
    Biochem Biophys Res Commun; 2015 Mar; 458(4):745-50. PubMed ID: 25686498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. microRNA-200c modulates the epithelial-to-mesenchymal transition in human renal cell carcinoma metastasis.
    Wang X; Chen X; Wang R; Xiao P; Xu Z; Chen L; Hang W; Ruan A; Yang H; Zhang X
    Oncol Rep; 2013 Aug; 30(2):643-50. PubMed ID: 23754305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Downregulation of miR-193a-3p inhibits cell growth and migration in renal cell carcinoma by targeting PTEN.
    Liu L; Li Y; Liu S; Duan Q; Chen L; Wu T; Qian H; Yang S; Xin D
    Tumour Biol; 2017 Jun; 39(6):1010428317711951. PubMed ID: 28639901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differentially expressed microRNA-218 modulates the viability of renal cell carcinoma by regulating BCL9.
    Wang J; Ying Y; Bo S; Li G; Yuan F
    Mol Med Rep; 2016 Aug; 14(2):1829-34. PubMed ID: 27314976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of spindle and kinetochore-associated protein 1 by antitumor miR-10a-5p in renal cell carcinoma.
    Arai T; Okato A; Kojima S; Idichi T; Koshizuka K; Kurozumi A; Kato M; Yamazaki K; Ishida Y; Naya Y; Ichikawa T; Seki N
    Cancer Sci; 2017 Oct; 108(10):2088-2101. PubMed ID: 28746769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of miR‑30b as an oncogene in renal cell carcinoma.
    Jin L; Li Y; He T; Hu J; Liu J; Chen M; Shi M; Jiang Z; Yang S; Mao X; Gui Y; Lai Y
    Mol Med Rep; 2017 Apr; 15(4):1837-1846. PubMed ID: 28259953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-19a correlates with poor prognosis of clear cell renal cell carcinoma patients via promoting cell proliferation and suppressing PTEN/SMAD4 expression.
    Ma Q; Peng Z; Wang L; Li Y; Wang K; Zheng J; Liang Z; Liu T
    Int J Oncol; 2016 Dec; 49(6):2589-2599. PubMed ID: 27779660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA‑24‑2 is associated with cell proliferation, invasion, migration and apoptosis in renal cell carcinoma.
    Jin L; Li Y; Nie L; He T; Hu J; Liu J; Chen M; Shi M; Jiang Z; Gui Y; Yang S; Lai Y
    Mol Med Rep; 2017 Dec; 16(6):9157-9164. PubMed ID: 28990105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor-suppressive microRNA-135a inhibits cancer cell proliferation by targeting the c-MYC oncogene in renal cell carcinoma.
    Yamada Y; Hidaka H; Seki N; Yoshino H; Yamasaki T; Itesako T; Nakagawa M; Enokida H
    Cancer Sci; 2013 Mar; 104(3):304-12. PubMed ID: 23176581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.